VITAMIN A ACID 0.05 %
TRETINOIN : 0.05 % · DIN 01926489 · BAUSCH HEALTH, CANADA INC.
Health Canada status: MARKETED
What is VITAMIN A ACID?
VITAMIN A ACID 0.05 % contains TRETINOIN : 0.05 %. It is listed in the Health Canada Drug Product Database under DIN 01926489, held by BAUSCH HEALTH, CANADA INC., supplied as GEL for TOPICAL administration. Health Canada currently lists it as marketed, status dated 30-Sep-2020. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is VITAMIN A ACID used for?
Topical application in the treatment of acne vulgaris, primarily Grades I, II and III in which comedones, papules and pustules predominate.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 01926489 |
|---|---|
| Brand name | VITAMIN A ACID |
| Generic / active ingredient | TRETINOIN : 0.05 % |
| Manufacturer | BAUSCH HEALTH, CANADA INC. |
| Strength | 0.05 % |
| Dosage form | GEL |
| Route of administration | TOPICAL |
| Schedule | Prescription |
| ATC code | D10AD01 TRETINOIN |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 30-Sep-2020 |
How is it administered?
Apply daily, preferably before retiring, using enough gel to lightly cover the affected area. Therapeutic results seen after 2-4 weeks; optimal results after 6-8 weeks.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
Store at controlled room temperature (15-30°C).
How is it supplied?
Supplied in tubes of 25 grams.
Contraindications
Hypersensitivity to any of the ingredients.
Warnings and precautions
Avoid application near eyes, mouth, nose, and mucous membranes. Avoid or minimize exposure to sunlight and sunlamps. Use SPF 15+ and protective clothing. May cause severe local irritation.
What can be used instead?
Other Canadian products sharing ATC code D10AD01 TRETINOIN. 6 of 31 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| RETIN-A | 0.025 % | GEL | BAUSCH HEALTH, CANADA INC. | MARKETED | DIN 00443816 |
| RETIN-A | 0.05 % | CREAM | BAUSCH HEALTH, CANADA INC. | MARKETED | DIN 00443794 |
| RETIN-A MICRO | 0.04 % | GEL | BAUSCH HEALTH, CANADA INC. | MARKETED | DIN 02264633 |
| RETIN-A MICRO | 0.1 % | GEL | BAUSCH HEALTH, CANADA INC. | MARKETED | DIN 02243914 |
| VITAMIN A ACID | 0.025 % | GEL | BAUSCH HEALTH, CANADA INC. | MARKETED | DIN 01926470 |
| ALTRENO | 0.05 % | LOTION | BAUSCH HEALTH, CANADA INC. | APPROVED | DIN 02510243 |
| REJUVA-A | 0.025 % | CREAM | GLAXOSMITHKLINE INC | CANCELLED POST MARKET | DIN 02192640 |
| RENOVA | 0.05 % | CREAM | VALEANT CANADA LP / VALEANT CANADA S.E.C. | CANCELLED POST MARKET | DIN 02052407 |
| RETIN-A | 0.01 % | CREAM | BAUSCH HEALTH, CANADA INC. | DORMANT | DIN 00897329 |
| RETIN-A | 0.01 % | GEL | BAUSCH HEALTH, CANADA INC. | DORMANT | DIN 00870013 |
Who else supplies TRETINOIN worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. TRETINOIN appears in 1362 registered pack listings across 7 markets, published on 6 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.